Company Filing History:
Years Active: 2016-2018
Title: Innovations by Benjamin M. Griffin
Introduction
Benjamin M. Griffin is a notable inventor based in San Diego, CA. He has made significant contributions to the field of chemical synthesis, particularly in the production of dicarboxylic acids. With a total of 4 patents to his name, Griffin's work is recognized for its innovative approaches and practical applications.
Latest Patents
Griffin's latest patents include groundbreaking methods for synthesizing 2,5-furan dicarboxylic acid (FDCA) and its precursors from gluconic acid derivatives. This invention outlines a chemical dehydration reaction involving gluconic acid derivatives in the presence of a dehydration catalyst. Notably, the derivatives can include 2-dehydro-3-deoxy gluconic acid (DHG), 2-ketogluconic acid (2KGA), and 5-ketogluconic acid (5KGA). The resulting FDCA precursor can be further converted into FDCA, showcasing a novel approach to producing valuable chemical compounds.
Another significant patent focuses on methods for producing dicarboxylic acids through the incubation of fatty acids or hydrocarbon substrates with specific enzymes. This process results in a dicarboxylic acid product that has undergone both over-oxidation and C—C bond cleavage. The invention highlights the use of cytochrome P450 enzyme mutants, particularly those from the CYP102 class, to achieve these results efficiently.
Career Highlights
Griffin is currently employed at Synthetic Genomics, Inc., where he continues to advance his research and development efforts. His work at this innovative company allows him to collaborate with other experts in the field and contribute to cutting-edge projects.
Collaborations
Griffin has worked alongside talented colleagues such as Spiros Kambourakis and Kevin V. Martin. Their collaborative efforts have further enhanced the impact of their research and innovations in the chemical synthesis domain.
Conclusion
Benjamin M. Griffin's contributions to the field of chemical synthesis are noteworthy, with his innovative patents paving the way for advancements in the production of dicarboxylic acids. His work at Synthetic Genomics, Inc. and collaborations with esteemed colleagues underscore his commitment to innovation and excellence in his field.